《MedRixv,2月27日,Spread and control of COVID-19 in China and their associations with population movement, public health emergency measures, and medical resources》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-28
  • Spread and control of COVID-19 in China and their associations with population movement, public health emergency measures, and medical resources

    Songmin Ying, Fei Li, Xinwei Geng, Zhouyang Li, Xufei Du, Haixia Chen, Sisi Chen, Min Zhang, Zhehua Shao, Yinfang Wu, Madiha Zahra Syeda, Fugui Yan, Luanqing Che, Bin Zhang, Jian Lou, Shaobin Wang, Zhengming Chen, Wen Li, Ye Shen, Zhihua Chen, Huahao Shen

    doi: https://doi.org/10.1101/2020.02.24.20027623

    Abstract

    ABSTRACT BACKGROUND The COVID-19 epidemic, first emerged in Wuhan during December 2019, has spread globally. While the mass population movement for Chinese New Year has significantly influenced spreading the disease, little direct evidence exists about the relevance to epidemic and its control of population movement from Wuhan, local emergency response, and medical resources in China.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.02.24.20027623v1
相关报告
  • 《LANCET,2月27日,Looming threat of COVID-19 infection in Africa: act collectively, and fast》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-28
    • Looming threat of COVID-19 infection in Africa: act collectively, and fast John N Nkengasong, Wessam Mankoula Published:February 27, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30464-5 Because of the high volume of air traffic and trade between China and Africa,1 Africa is at a high risk for the introduction and spread of the novel coronavirus disease 2019 (COVID-19); although only Egypt has reported the first case, from a non-national.2 The greatest concern for public health experts is whether COVID-19 will become a pandemic, with sustained year-round transmission, similar to influenza, as is now being observed in several countries.3 What might happen to Africa—where most countries have weak health-care systems, including inadequate surveillance and laboratory capacity, scarcity of public health human resources, and limited financial means—if a pandemic occurs? With neither treatment nor vaccines, and without pre-existing immunity, the effect might be devastating because of the multiple health challenges the continent already faces: rapid population growth and increased movement of people; existing endemic diseases, such as human immunodeficiency virus, tuberculosis, and malaria; remerging and emerging infectious pathogens such as Ebola virus disease, Lassa haemorrhagic fever, and others; and increasing incidence of non-communicable diseases.
  • 《MedRixv,2月27日,Illness and Fatality Risks of COVID-19 of General Public in Hubei Provinces and Other Parts of China》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-02-28
    • Illness and Fatality Risks of COVID-19 of General Public in Hubei Provinces and Other Parts of China YUNGANG HE doi: https://doi.org/10.1101/2020.02.25.20027672 Abstract New coronavirus 2019-nCOV poses a big challenge for global public health in early 2020. Coronavirus Disease 2019 (COVID-19) caused by the virus rapidly spreads all over the world and takes thousands of lives in just two months. To assess illness and fatality risk of the viral infection is exceedingly helpful to ensure effective management of the general public and patients in the outbreak. Therefore, it is critical to quantify illness and fatality risk of COVID-19 for the general public. In this report, we investigate the illness and fatality risk of the infection by analyzing the age composition of 5319 infected patients, 76 mortality cases, and 1,144,648 individuals of the general public in China. Our result shows a relatively low illness risk for young people but a very high fatality risk for seniors. Notably, fatality risk could be as high as 0.48 for people older than 80 years. Furthermore, our study suggests that a good medical service can effectively reduce the mortality rate of the viral infection to 1% or less. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.